Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional CohortLauren Folgosa Cooley, William J. Catàlona, Adaeze A. Emeka et al.|The Journal of Urology|2021Cited by 28
Genetic factors associated with prostate cancer conversion from active surveillance to treatmentYu Jiang, Phillip R. Cooper, Nicola Lancki et al.|Human Genetics and Genomics Advances|2021Cited by 23
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to TreatmentYu Jiang, Travis J. Meyers, Adaeze A. Emeka et al.|medRxiv|2021Cited by 14